Top

Cancer Causes & Control

Published in:

01-06-2003

Prescription medication use during pregnancy and risk of infant leukemia (United States)

Authors: Julie A. Ross, Yang Xie, Stella M. Davies, Xiao-ou Shu, Thomas W. Pendergrass, Leslie L. Robison

Published in: Cancer Causes & Control | Issue 5/2003

Title: Prescription medication use during pregnancy and risk of infant leukemia (United States)
Authors: Julie A. Ross
Yang Xie
Stella M. Davies
Xiao-ou Shu
Thomas W. Pendergrass
Leslie L. Robison
Publication date: 01-06-2003
Publisher: Kluwer Academic Publishers-Plenum Publishers
Published in: Cancer Causes & Control / Issue 5/2003
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/A:1024953532355

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2003

Micronutrients and laryngeal cancer risk in Italy and Switzerland: a case–control study

Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)

Salt intake, cured meat consumption, refrigerator use and stomach cancer incidence: a prospective cohort study (Netherlands)

Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa)

Number and size of nevi are influenced by different sun exposure components: implications for the etiology of cutaneous melanoma (Belgium, Germany, France, Italy)

Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention

Keynote webinar | Spotlight on antibody–drug conjugates in cancer